Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 4 | Mind Blowing Facts

Morbius: Jared Leto says cinemas might no longer exist without Marvel films

The star, who is set to play Morbius in a new comic book film, seemed to credit Marvel with keeping movie theatres open in a new interview

Evening Standard

Albert Labs, Psychedelic Biotech Company Shares Now Available On Canadian Exchange

Albert Labs, Psychedelic Biotech Company Shares Now Available On Canadian Exchange

Albert Labs, a British-Columbia based biotech company, announced Thursday that it closed its private placement and that its shares will begin trading on the Canadian Securities Exchange (CSE). Albert Labs will trade under the ticker symbol “ABRT.”

Pandora launch four-leaf clover charm for under £20 for St Patrick's Day

Pandora launch four-leaf clover charm for under £20 for St Patrick's Day

The lucky charm is the perfect gift for someone celebrating the Irish holiday on March 17

Manchester Evening News

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This Colorful McLaren Puts Art In The Artura Hybrid Supercar

It will be displayed at the ME Dubai hotel until March 31, 2021.

23andMe's Q3 Topline Beat Estimates On Boost From Telehealth Business Acquisition

23andMe Holding Co (NASDAQ: ME) has updated its FY22 guidance following the inclusion of telehealth operations into its consumer business.

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

Here's a roundup of top developments in the biotech space over the last 24 hours:

Why Jim Cramer Like NextEra Energy And Lincoln Electric?

On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE: NEE) is the "fastest growing utility." He recommended buying the stock today morning.

inkl

Read news from The Economist, FT, and more,
with one subscription

23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?

23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?

Genetic testing company 23andMe Holding Co.

1 2 3 4

People

Michael Morbius

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Canadian Securities Exchange

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play